What Researchers Did
This study investigated the role of hypoxia in the resistance of brain tumours to treatment and their progression towards increased malignancy.
What They Found
Researchers found that extensive and severe hypoxia in brain tumours, particularly gliomas, significantly contributes to their resistance to radiation and many common anticancer drugs. They also observed that hypoxia drives tumour evolution towards increased malignancy by inducing gene expression changes, mutations, and selecting for more aggressive cell phenotypes, potentially explaining the progression from low-grade malignancies to aggressive glioblastomas.
Canadian Relevance
This study has no direct Canadian connection as it was not conducted in Canada nor involved Canadian researchers or patients.
Study Limitations
A limitation of this study is its focus on reviewing existing knowledge and mechanisms of hypoxia, rather than presenting new experimental data or specific clinical trial outcomes.